Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1756-9966
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma ; volume:41 ; number:1 ; day:17 ; month:11 ; year:2022 ; pages:1-19 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (17.11.2022), 1-19, 12.2022

Creator
Lucarini, Valeria
Melaiu, Ombretta
D’Amico, Silvia
Pastorino, Fabio
Tempora, Patrizia
Scarsella, Marco
Pezzullo, Marco
Ninno, Adele De
D’Oria, Valentina
Cilli, Michele
Emionite, Laura
Infante, Paola
Marcotullio, Lucia Di
Ioris, Maria Antonietta De
Barillari, Giovanni
Alaggio, Rita
Businaro, Luca
Ponzoni, Mirco
Locatelli, Franco
Fruci, Doriana
Contributor
SpringerLink (Online service)

DOI
10.1186/s13046-022-02525-9
URN
urn:nbn:de:101:1-2023013021042297212025
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Lucarini, Valeria
  • Melaiu, Ombretta
  • D’Amico, Silvia
  • Pastorino, Fabio
  • Tempora, Patrizia
  • Scarsella, Marco
  • Pezzullo, Marco
  • Ninno, Adele De
  • D’Oria, Valentina
  • Cilli, Michele
  • Emionite, Laura
  • Infante, Paola
  • Marcotullio, Lucia Di
  • Ioris, Maria Antonietta De
  • Barillari, Giovanni
  • Alaggio, Rita
  • Businaro, Luca
  • Ponzoni, Mirco
  • Locatelli, Franco
  • Fruci, Doriana
  • SpringerLink (Online service)

Other Objects (12)

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

TH9 cells in anti-tumor immunity

TH9 cells in anti-tumor immunity

Cytokine-induced killer cells promote antitumor immunity

Cytokine-induced killer cells promote antitumor immunity

Induction of antitumor immunity through xenoplacental immunization

Induction of antitumor immunity through xenoplacental immunization

Impairment of NKG2D-mediated tumor immunity by TGF-β

Impairment of NKG2D-mediated tumor immunity by TGF-β

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

Necroptosis stimulates interferon-mediated protective anti-tumor immunity

Necroptosis stimulates interferon-mediated protective anti-tumor immunity

Tumor immune microenvironment (TIME) to enhance antitumor immunity

Tumor immune microenvironment (TIME) to enhance antitumor immunity

Integrin CD11b activation drives anti-tumor innate immunity

Integrin CD11b activation drives anti-tumor innate immunity

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors

Hochschulschrift

Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors

Targeting tumor cells with antibodies enhances anti-tumor immunity

Targeting tumor cells with antibodies enhances anti-tumor immunity

Related objects